Emerging Pharmaceutical Market in China - Forecast to Become The World’s Third-Largest Pharmaceutical Market By 2013
- Language: English
- 85 Pages
- Published: September 2011
- Region: China
There are many big local companies that are playing key roles in the Chinese healthcare industry, covering biotech, medical technology and pharmaceutical markets. With more local resources and better understanding of the Chinese market, these local companies had achieved enough shares and are the key competitors of most multinational companies.
China National Medicines Corporation Ltd. (SinoPharm CNMC Ltd.) is one of the leading pharmaceutical companies in the Chinese drug distribution area. With SinoPharm as its key parent company, it had achieved revenues of RMB 7.0 billion in 2011. This report will provide you with more insightful information of SinoPharm CNMC Ltd., covering its history, business, revenues and costs, people, shareholders and subsidiaries, recent activities and future development.
Purely focusing on the Chinese healthcare industry, ChinaBionews is able to track and dig more detailed information with Shanghai based Chinese native analysts. Before delivering the report, ChinaBionews will check if there is any new info available, such as quarterly revenues and recent activities, to make sure that the report is mostly updated.
Reasons of Buying
More original information based on the Chinese language
Detailed analysis of the company
Strong after sale support to clients who have access to Shanghai-based experienced analysts for further questions
Who should Buy
Decision makers who are looking for M&A opportunities in China
Decision makers who are responsible for market intelligence in China
Decision makers who are responsible for business development in China
Consultants SHOW LESS READ MORE >
1. SinoPharm CNMC Ltd. Overview
2.1 Balance Sheet
2.1.2 Liabilities & Equity
2.2.1 Annual Revenues
2.2.2 Quarterly Revenues
2.3.1 Sales & Marketing Costs
2.3.2 R&D Expenditure
2.3.3 Other Costs
3.1 Board of Director
3.2 Management Team
4.1 Risk Analysis
4.2 Recent Activities
4.3 Future Development
5. Directory of SinoPharm CNMC Ltd.’s Related Companies
List of Figures
Figure 1: Infrastructure of SinoPharm CNMC Ltd.
Figure 2: Top Shareholders of SinoPharm CNMC Ltd.
Figure 3: Parent Companies of SinoPharm CNMC Ltd.
Figure 4: Total Assets of SinoPharm CNMC Ltd.
Figure 5: Liability Ratio of SinoPharm CNMC Ltd.
Figure 6: Annual Revenues of SinoPharm CNMC Ltd.
Figure 7: Regional Revenues of SinoPharm CNMC Ltd. in 2011
Figure 8: Quarterly Revenues of SinoPharm CNMC Ltd.
Figure 9: Sales & Marketing Cost of SinoPharm CNMC Ltd.
Figure 10: R&D Expenditure of SinoPharm CNMC Ltd.
Figure 11: Gross Profit of SinoPharm CNMC Ltd.
Figure 12: Number of Employees of SinoPharm CNMC Ltd. in 2011
List of Tables
Table 1: Subsidiary Companies of SinoPharm CNMC Ltd.
Table 2: Board and Management Members of SinoPharm CNMC Ltd.
Table 3: Directory of SinoPharm CNMC Ltd.’s Related Companies
China National Medicines Co., Ltd., SinoPharm